Among the companies with shares expected to trade actively in
Thursday's session are Raytheon Co. (RTN), Thermo Fisher
Scienti-fic Inc. (TMO) and Alexion Pharmaceuticals Inc. (ALXN).
Raytheon on Thursday raised its full-year profit guidance,
completing a clean sweep of improved outlooks among the largest
U.S. military contractors, which have driven their share prices to
record highs. Shares rose 2.63% to $138.90 in premarket
trading.
Thermo Fisher Scientific edged its earnings guidance higher for
the year after revenue rose 6.2% in the latest quarter, boosted by
the company's recent acquisitions, as the lab-equipment company
readies to buy FEI Co. Shares fell 0.57% to $158 premarket.
Alexion Pharmaceuticals reported that revenue increased but
profit fell as the rare-drug market continues to ramp up sales of
new drugs. Shares fell 0.6% to $129.00 premarket.
Dow Chemical Co. (DOW) reported revenue slid less than
anticipated and earnings easily topped expectations in the latest
quarter despite continued pricing and currency headwinds. Shares
rose 0.69% to $54 premarket.
Oracle Corp. (ORCL) agreed to buy NetSuite Inc. (N) for $9.3
billion, bolstering the software maker's cloud-computing offerings
as it races to catch up to rivals. Oracle shares rose 1.95% to
$41.73 premarket. NetSuite shares rose 18% to $108.15
premarket.
Colgate-Palmolive Co. (CL) reported revenue slid more than
expected in the most recent quarter as foreign currency headwinds
dragged down results, particularly in Latin America.
ConocoPhillips (COP) said its second-quarter loss widened as
revenue slumped amid the prolonged commodities downturn.
Hershey Co. (HSY) said Thursday that it swung to a profit and
posted revenue gains in its latest quarter; however, it was hurt by
lower-than-expected growth in its candy, mint and gum segment.
Celgene Corp. (CELG) bumped up its earnings forecast for the
year after sales of its flagship drug unexpectedly picked up.
GNC Holdings Inc. (GNC) replaced its chief executive Thursday
and suspended its earnings guidance as the health and wellness
retailer works to turn itself around and continues a strategic
review that could result in a sale of the company.
Mattress maker Tempur Sealy International Inc. (TPX) reported
better-than-expected profit in the latest period, helped by
climbing revenue amid lower overall expenses.
Spectrum Brands Holdings Inc. (SPB) posted better-than-expected
earnings in the most recent quarter on continued strength in its
hardware and home improvement, battery and home and garden
segments.
Alcoa Inc. (AA) plans to cut the number of its publicly traded
shares with a 1-for-3 reverse stock split, as the aluminum maker
prepares to split into two companies. A special shareholder meeting
is scheduled for Oct. 5.
AllianceBernstein LP (AB) said Wednesday that it won't pursue a
deal to buy a fund from hedge fund firm Visium Asset Management
LP.
Amgen Inc.'s (AMGN) second-quarter profit rose 13% on
higher-than-expected revenue, which was again driven by sales of
key drugs such as Enbrel.
Cheesecake Factory Inc. (CAKE) on Wednesday increased its
stock-buyback plan, raised its dividend and posted
better-than-expected profit for its latest quarter.
Facebook Inc. (FB) on Wednesday topped $2 billion in quarterly
profit, six months after crossing the billion dollar mark for the
first time, as the number of new users--and the ad dollars that
follow them--surged in the second quarter.
Fortune Brands Home & Security Inc. (FBHS)--the maker of
MasterBrand cabinets, Moen faucets and Master Lock security
products--on Wednesday raised further its financial projections for
the year as it reported another big increases in quarterly profit,
tied to a strong market for home products.
GoPro Inc. (GPRO) swung to a second-quarter loss, its third
consecutive loss, as revenue dropped in nearly half. Chief
Executive Nick Woodman said the company expects to return to
profitability in the holiday quarter with the release of its next
flagship camera, the Hero5.
Discount deals company Groupon Inc. (GRPN) on Wednesday reported
better-than-expected results, driven by North America, where it
added more than 1 million customers and reported a 9% increase in
local billings.
IAC/InterActiveCorp. (IAC), which last year spun off its dating
websites as Match Group Inc., on Wednesday swung to a
second-quarter loss as it wrote down the value of its publishing
segment.
Legg Mason Inc.'s (LM) second-quarter profit tumbled by nearly
two-thirds as skittish investors pulled money from stocks and
alternative investments and as the asset manager booked
merger-related charges.
Marriott International Inc.'s (MAR) second-quarter profit rose
2.9% as it nears the close of its pending deal for Starwood Hotels
& Resorts Worldwide Inc.
McKesson Corp.'s (MCK) profit in the latest quarter fell 4%,
reflecting a loss on the sale of a Brazilian business, but adjusted
earnings increased as the drug wholesaler said results were
consistent with expectations.
Mylan NV (MYL) has received U.S. regulatory approval for its
roughly $7.2 billion purchase of Swedish rival Meda, conditioned on
Mylan divesting itself of rights to two generic drugs. The Federal
Trade Commission's approval was the last regulatory step needed to
complete the Meda deal.
O'Reilly Automotive Inc. (ORLY) on Wednesday posted
second-quarter profit above the company's estimates as same-store
sales came in near the top of its quarterly guidance.
Pilgrim's Pride Corp. (PPC) on Wednesday reported another sharp
drop in quarterly profit amid domestic weakness. Sales in the U.S.,
which account for the bulk of the company's business, fell 8.8% in
the latest period.
Six Flags Entertainment Corp. (SIX) reported
better-than-expected revenue in its latest quarter as the
theme-park operator saw increased turnout and higher guest
spending, highlighting consumers' willingness to spend on
experiences over goods.
Taikang Life Insurance Co. has disclosed a 13.5% stake in
Sotheby's (BID), citing a "positive view" of the auction company's
prospects as well as potential interest in a board seat.
Teva Pharmaceutical Industries Ltd. (TEVA) on Wednesday won
regulatory approval from the Federal Trade Commission for its
acquisition of Allergan PLC's (AGN) generics business, conditioned
upon Teva's divestiture of 75 drugs to rivals.
Vertex Pharmaceuticals Inc.'s (VRTX) second-quarter loss
narrowed, as sales of its cystic fibrosis drugs continued to
increase. The Boston-based biopharmaceutical company's top- and
bottom-line results beat expectations.
Whole Foods Market Inc. (WFM) on Wednesday gave weak projections
for the current quarter as it booked its fourth-consecutive decline
in quarterly profit and a key sales metric.
Xilinx Inc.'s (XLNX) quarterly profit rose 10% as the
programmable chip maker's newer products continued to drive
sales.
Write to Chris Wack at chris.wack@wsj.com or Maria Armental at
maria.armental@wsj.com
(END) Dow Jones Newswires
July 28, 2016 09:27 ET (13:27 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Arconic (NYSE:ARNC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Arconic (NYSE:ARNC)
Historical Stock Chart
From Sep 2023 to Sep 2024